CRISPR Therapeutics AG Overview
CRISPR Therapeutics AG Target Price
Analysts' 12-month price predictions for CRSP.
Share Price
$36.14
Average Target Price
$65.00
79.9% upside
79.9% upside1 analysts in the last 4 months
High: $65 | Low: $65
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-02-03 | H.C. WainwrightMitchell Kapoor | $65 | 79.9% upside |  |
| 2024-11-06 | OppenheimerJay Olson | $95 | 162.9% upside | |
| 2024-11-05 | Leerink PartnersRick Bienkowski | $67 | 85.4% upside | |
| 2024-08-12 | Truist FinancialJoon Lee | $100 | 176.7% upside | |
| 2024-08-06 | NeedhamGil Blum | $84 | 132.4% upside | |
| 2024-08-06 | Stifel NicolausBenjamin Burnett | $59 | 63.3% upside | |
| 2024-08-06 | RBC CapitalLuca Issi | $60 | 66% upside | |
| 2024-05-09 | Robert W. BairdJack Allen | $52 | 43.9% upside | |
| 2022-11-23 | Citigroup | $63 | 74.3% upside | |
| 2022-08-09 | Chardan CapitalGeulah Livshits | $79.3 | 119.4% upside | |
| 2022-06-17 | BMO CapitalKostas Biliouris | $98 | 171.2% upside | |
| 2022-04-28 | Credit Suisse | $78 | 115.8% upside | |
| 2022-02-16 | NeedhamGil Blum | $170 | 370.4% upside | |
| 2022-02-15 | Leerink PartnersRick Bienkowski | $120 | 232% upside | |
| 2022-01-07 | Wells FargoYanan Zhu | $105 | 190.5% upside | |
| 2021-11-04 | OppenheimerJay Olson | $172 | 375.9% upside | |
| 2021-10-12 | Piper SandlerEdward Tenthoff | $180 | 398.1% upside | |
| 2021-08-16 | Canaccord GenuityArlinda Lee | $160 | 342.7% upside | |
| 2021-06-11 | Roth CapitalAnthony Butler | $171 | 373.2% upside | |
| 2021-04-21 | JefferiesMaury Raycroft | $172 | 375.9% upside | |